Livzon Pharmaceutical board to review nine-month results

Livzon Pharmaceutical Group Inc. announced its board of directors will convene on Thursday, October 23, 2025. The primary agenda for this meeting is the consideration and approval of the company’s unaudited quarterly results, encompassing the performance of the company and its subsidiaries for the nine months ended September 30, 2025. The board will also address any other business as required.

As of the announcement date, the executive leadership includes Mr. Tang Yanggang as president, and Mr. Xu Guoxiang as vice chairman and vice president. Non-executive directors comprise Mr. Zhu Baoguo (chairman), Mr. Tao Desheng (vice chairman), Mr. Lin Nanqi, and Mr. Qiu Qingfeng. The independent non-executive directors are Mr. Bai Hua, Mr. Tian Qiusheng, Mr. Wong Kam Wa, Mr. Luo Huiyuan, and Ms. Cui Lijie. The announcement was made in Zhuhai, China, on October 9, 2025.